Pancreatic Cancer Research

ResearcherTufts UniversityNo recent work listed

Sebastián Mellado

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5070106374. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

  1. R1 pancreatic cancer patients benefit from chemoradiation when initiation of adjuvant therapy is delayed. Co-author DOI 10.1016/j.suronc.2023.101961↗
  2. Trends in Preoperative Chemotherapy Utilization for Proximal Pancreatic Cancer: Are We Making Progress? Co-author DOI 10.1007/s11605-022-05336-7↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Claudius H. Conrad · 2 shared papers, 2022–2023 · strength 0.33
  2. Onur Cagri Kutlu · 2 shared papers, 2022–2023 · strength 0.33
  3. Eduardo A. Vega · 2 shared papers, 2022–2023 · strength 0.33
  4. Ariana M. Chirban · 1 shared paper, 2023 · strength 0.18
  5. Oscar Salirrosas · 1 shared paper, 2023 · strength 0.18
  6. Omid Salehi · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.